EIDX News and Press, Eidos Therapeutics Inc. From 10/29/20

SAN FRANCISCO, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today reported its financial results for the third quarter ended September 30, 2020 and provided an update on the company’s operations. “The completion of enrollment in our P...

NEW YORK, NY / ACCESSWIRE / October 24, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Standard AVB Financial Corp. (NASDAQ:STND) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to...

NEW YORK, NY / ACCESSWIRE / October 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: MyoKardia, Inc. (NASDAQ:MYOK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bristol-Mye...

NEW YORK, NY / ACCESSWIRE / October 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Eidos Therapeutics, Inc. (NASDAQ:EIDX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bridg...

NEW YORK, NY / ACCESSWIRE / October 20, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Eidos Therapeutics, Inc. (NASDAQ: EIDX ) rela...

As the pandemic resurges, early vaccine trials are reaching the home stretch. Vaccine results now pushed back to mid-to-late November at the earliest, and there have been delays in therapeutic treatments. Healthcare overall has been burdened by the uncertainty on the Affordable Ca...

Merger activity moderated again last week with three new deals announced. The acquisition of Acorn International by First Ostia Port. The merger of DouYu International Holdings Limited and HUYA Inc. For further details see: Merger Arbitrage Mondays - 2 Potential Deals Co...

NEW YORK, NY / ACCESSWIRE / October 13, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: MyoKardia, Inc. (NASDAQ:MYOK) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bristol-Myers ...

Merger activity decreased last week with four new deals announced. The acquisition of MyoKardia by Bristol Myers Squibb Company. The acquisition of Eaton Vance by Morgan Stanley. For further details see: Merger Arbitrage Mondays - Bristol Myers Squibb...

WILMINGTON, Del., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Eidos Therapeut...